Trice Medical Launches Tenex® 2nd Generation Ultrasonic System, Expanding Minimally Invasive Treatment For Chronic Tendon Paid

Trice Medical announced nationwide commercial availability of the FDA-cleared Tenex® 2nd Generation System, building on the proven Tenex Health TX® platform that has been used in more than 240,000 procedures. The Tenex 2nd Generation System is an advanced platform designed to expand minimally invasive ultrasonic procedures for the treatment of chronic tendon disease and other musculoskeletal conditions, including calcific deposits, bone spurs, and diabetic foot ulcers.